BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Waldenstrom Macroglobulinemia

Below is an extended Waldenstrom Macroglobulinemia research listing. Click here to return to the Waldenstrom Macroglobulinemia main in depth entry.

Recent Publications on Waldenstrom Macroglobulinemia:

Malignant hematopoietic cell lines: in vitro models for the study of Waldenstrom's macroglobulinemia.
Model cell lines are essential tools for investigating the biology and...
Direct Link
4th October, 2008
DSMZ-German Collection of Microorganisms and Cell Cultures, Department of
The use of cell lines for the study of Waldenstrom's macroglobulinemia.
In this issue of Leukemia Research, Drexler and MacLeod raise questions...
Direct Link
4th October, 2008
Neurological manifestations of Waldenstrom macroglobulinemia.
Waldenstrom macroglobulinemia, a condition that most commonly occurs in...
Direct Link
25th September, 2008
Yale University School of Medicine, Yale Brain Tumor Center, New Haven,
Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia.
BACKGROUND: Certain autoimmune and infectious conditions are associated...
Direct Link
24th September, 2008
Cancer Prevention Fellowship Program, Office of Preventive Oncology, and
Scintigraphic pattern of skeletal involvement of Waldenstrom macroglobulinemia.
Lymphoplasmacytic lymphoma (LPL) is a small B-cell lymphoma with...
Direct Link
11th September, 2008
Department of Pathology, Ain Shams University, Egypt.
Cytological detection of lymphoma in Douglas aspirate.
Except in primary effusion lymphoma (PEL), serous effusions with...
Direct Link
6th September, 2008
Department of Pathology and Cytology, General Hospital Sveti Duh, Zagreb.
WSU-WM and BCWM.1 should not be assumed to represent Waldenstrom macroglobulinemia cell lines.
Lymphoplasmacytic lymphoma (LPL) is a small B-cell lymphoma with...
Direct Link
6th September, 2008
Current treatment options for waldenstrom macroglobulinemia.
Waldenstrom macroglobulinemia (WM) is a lymphoma characterized by...
Direct Link
4th September, 2008
Division of Hematology (M.A.G.), Mayo Clinic, Rochester, MN.
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study.
Lymphoplasmacytic lymphoma (LL) is incurable by standard therapy (median...
Direct Link
30th August, 2008
Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
Targeted therapies in Waldenstrom macroglobulinemia. 30th August, 2008
Dana Farber Cancer Institute, Department of Medical Oncology, 44 Binney
Fluorescence Immunophenotypic and Interphase Cytogenetic Characterization of Nodal Lymphoplasmacytic Lymphoma.
Lymphoplasmacytic lymphoma (LPL) is a small B-cell lymphoma with...
Direct Link
2nd August, 2008
*Department of Pathology, University of Pittsburgh School of Medicine
Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia. 2nd August, 2008
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan
Multiple myeloma and immunosecretory disorders: an update.
The immunosecretory disorders are a diverse group of diseases associated...
Direct Link
30th July, 2008
Department of Pathology, Veterans Affair Medical Center, Louisville, KY,
Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma.
Lymphoplasmacytic lymphoma (LL) is incurable by standard therapy (median...
Direct Link
9th July, 2008
Waldenstrom macroglobulinemia.
In the past years, new developments have occurred both in the...
Direct Link
17th June, 2008
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional